Dataset from Diabetes Prevention Program

The Diabetes Prevention Program is a nationwide clinical study to answer the question: Can
Type 2 diabetes (also called noninsulin-dependent or adult-onset diabetes) be prevented or
delayed? The study has recruited volunteers, who are at high risk of developing diabetes, at
twenty-five medical centers in the United States. It is sponsored by the National Institute
of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health, and other
Institute and corporate sponsors. Researchers will evaluate the efficacy of a lifestyle
intervention and a pharmacological intervention in preventing or delaying Type 2 diabetes in
persons with impaired glucose tolerance (IGT). Each person in the study will be followed for
3 to 6 years.